Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction
Authors
Keywords
-
Journal
JACC-Basic to Translational Science
Volume 6, Issue 11, Pages 918-932
Publisher
Elsevier BV
Online
2021-11-23
DOI
10.1016/j.jacbts.2021.07.010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extracardiac Abnormalities of Preload Reserve
- (2021) Marat Fudim et al. Circulation-Heart Failure
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical implications of renin–angiotensin system inhibitors for development and progression of non-alcoholic fatty liver disease
- (2021) Kwang Min Kim et al. Scientific Reports
- Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT
- (2021) Anthony E. Peters et al. ESC Heart Failure
- Meta-Analysis of Efficacy of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction
- (2021) Husam M. Salah et al. AMERICAN JOURNAL OF CARDIOLOGY
- Branched-chain α-ketoacids are preferentially reaminated and activate protein synthesis in the heart
- (2021) Jacquelyn M. Walejko et al. Nature Communications
- Lymphatic Dysregulation in Patients With Heart Failure
- (2021) Marat Fudim et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Osteopontin – A potential biomarker of advanced liver disease
- (2020) Radan Bruha et al. Annals of Hepatology
- Effects of SGLT2 Inhibitors on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Meta‐Analysis of Randomized Controlled Trials
- (2020) Baodi Xing et al. Journal of Diabetes Investigation
- Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction
- (2020) Kota Suzuki et al. EUROPEAN JOURNAL OF HEART FAILURE
- Plasma BCAA Changes in Patients With NAFLD Are Sex Dependent
- (2020) Guillaume Grzych et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Associations of inflammatory markers with impaired left ventricular diastolic and systolic function in collagen-induced arthritis
- (2020) Lebogang Mokotedi et al. PLoS One
- Spontaneous porto-systemic shunts in liver cirrhosis: Clinical and therapeutical aspects
- (2020) Silvia Nardelli et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Regional adiposity and heart failure with preserved ejection fraction
- (2020) Vishal N. Rao et al. EUROPEAN JOURNAL OF HEART FAILURE
- Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis
- (2020) Guillaume Lassailly et al. GASTROENTEROLOGY
- Lower levels of plasma NT-proBNP are associated with higher prevalence of NASH in patients with biopsy-proven NAFLD
- (2020) Zeng-Pei Qiao et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction
- (2020) Alexandria Miller et al. Scientific Reports
- Effect of sodium-glucose Cotransporter 2 inhibitors on cardiovascular and kidney outcomes – Systematic review and meta-analysis of randomized placebo-controlled trials
- (2020) Husam M. Salah et al. AMERICAN HEART JOURNAL
- SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
- (2020) Faiez Zannad et al. LANCET
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- The prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria
- (2020) Marcel Razpotnik et al. LIVER INTERNATIONAL
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update
- (2020) Husam M. Salah et al. AMERICAN HEART JOURNAL
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology
- (2019) Wilfried Mullens et al. EUROPEAN JOURNAL OF HEART FAILURE
- Branched-chain amino acids in disease
- (2019) Phillip J. White et al. SCIENCE
- Nonalcoholic Fatty Liver Disease and the Heart
- (2019) Eric P. Stahl et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Osteopontin – a biomarker of disease, but also of stage stratification of the functional myocardial contractile deficit by chronic ischaemic heart disease
- (2019) Bogdan-Ioan Coculescu et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Relationship of Liver Stiffness With Congestion in Patients Presenting With Acute Decompensated Heart Failure
- (2019) Anzhela Soloveva et al. JOURNAL OF CARDIAC FAILURE
- Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial
- (2019) Maurice B. Bizino et al. Cardiovascular Diabetology
- Redefining Cirrhotic Cardiomyopathy For The Modern Era
- (2019) Manhal Izzy et al. HEPATOLOGY
- Metabolic syndrome is an inflammatory disorder: A conspiracy between adipose tissue and phagocytes
- (2019) Priya Reddy et al. CLINICA CHIMICA ACTA
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- (2019) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications
- (2019) Claudio Tana et al. International Journal of Environmental Research and Public Health
- Dietary branched-chain amino acid restriction alters fuel selection and reduces triglyceride stores in hearts of Zucker fatty rats
- (2019) Robert W. McGarrah et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
- (2019) Cong Wang et al. CYTOKINE
- Serum levels of gamma-glutamyltransferase predict outcome in heart failure with preserved ejection fraction
- (2019) Daniel Dalos et al. Scientific Reports
- Diagnosis, Treatment, and Management of Orthotopic Liver Transplant Candidates With Portopulmonary Hypertension
- (2018) Anna Koulava et al. Cardiology in Review
- The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase
- (2018) Phillip J. White et al. Cell Metabolism
- Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
- (2018) Lesley Hoyles et al. NATURE MEDICINE
- Spironolactone in Combination with α-glycosyl Isoquercitrin Prevents Steatosis-related Early Hepatocarcinogenesis in Rats through the Observed NADPH Oxidase Modulation
- (2018) Hirotada Murayama et al. TOXICOLOGIC PATHOLOGY
- GLP-1 Improves Diastolic Function and Survival in Heart Failure with Preserved Ejection Fraction
- (2018) T. Dung Nguyen et al. Journal of Cardiovascular Translational Research
- Burden of Liver Diseases in the World
- (2018) Sumeet K. Asrani et al. JOURNAL OF HEPATOLOGY
- Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study
- (2018) Kara Wegermann et al. PLoS One
- Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-Analysis
- (2018) Yung Lee et al. Clinical Gastroenterology and Hepatology
- Inflammatory markers and left ventricular diastolic dysfunction in a family-based population study
- (2018) Małgorzata Kloch et al. Kardiologia Polska
- Long-term cardiovascular changes following creation of arteriovenous fistula in patients with end stage renal disease
- (2017) Yogesh N. V. Reddy et al. EUROPEAN HEART JOURNAL
- The impact of non-alcoholic fatty liver disease fibrosis score on cardiac prognosis in patients with chronic heart failure
- (2017) Tetsuya Takahashi et al. HEART AND VESSELS
- Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance
- (2017) Melania Gaggini et al. HEPATOLOGY
- Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
- (2017) Anna M. Diehl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bariatric Surgery-Induced Cardiac and Lipidomic Changes in Obesity-Related Heart Failure with Preserved Ejection Fraction
- (2017) Deana Mikhalkova et al. Obesity
- Is Fatty Liver a Risk Marker for Heart Failure?
- (2017) Lisa B. VanWagner Obesity
- Nonalcoholic Steatohepatitis is Associated with Cardiac Remodeling and Dysfunction
- (2017) Tracey G. Simon et al. Obesity
- Value of Virtual Touch Quantification Elastography for Assessing Liver Congestion in Patients With Heart Failure
- (2016) Takashi Yoshitani et al. CIRCULATION JOURNAL
- Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice
- (2016) Giulio Marchesini et al. HEPATOLOGY
- Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
- (2016) Sven M. Francque et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Computerized tomography measured liver fat is associated with low levels of N-terminal pro-brain natriuretic protein (NT-proBNP). Multi-Ethnic Study of Atherosclerosis
- (2016) Otto A. Sanchez et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Branched-chain amino acid restriction in Zucker-fatty rats improves muscle insulin sensitivity by enhancing efficiency of fatty acid oxidation and acyl-glycine export
- (2016) Phillip J. White et al. Molecular Metabolism
- Differential Sympathetic Vasomotor Activation Induced by Liver Cirrhosis in Rats
- (2016) Heder F. G. Estrela et al. PLoS One
- Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study
- (2015) Lisa B. VanWagner et al. HEPATOLOGY
- Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease
- (2015) Tommy Pacana et al. PLoS One
- Nonalcoholic Fatty Liver Disease: Portal Hypertension Due to Outflow Block in Patients without Cirrhosis
- (2015) Masashi Hirooka et al. RADIOLOGY
- Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease
- (2014) April D. Lake et al. AMINO ACIDS
- Cirrhotic cardiomyopathy: review of pathophysiology and treatment
- (2014) Maneerat Chayanupatkul et al. Hepatology International
- Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
- (2014) Hannele Yki-Järvinen Lancet Diabetes & Endocrinology
- Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet
- (2013) Tsutomu Wada et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Interactions of the heart and the liver
- (2013) Søren Møller et al. EUROPEAN HEART JOURNAL
- Impaired left ventricular mechanics in nonalcoholic fatty liver disease
- (2013) Can Y. Karabay et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Left atrial function is impaired in cirrhosis: a speckle tracking echocardiographic study
- (2013) Francisco Sampaio et al. Hepatology International
- Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial
- (2012) Andrew P. Ambrosy et al. EUROPEAN JOURNAL OF HEART FAILURE
- Congestive hepatopathy and hypoxic hepatitis in heart failure: A cardiologist's point of view
- (2012) Ausra Kavoliuniene et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis
- (2011) A Shuster et al. BRITISH JOURNAL OF RADIOLOGY
- Non-alcoholic fatty liver disease
- (2011) Briohny W. Smith et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Lipids in the Wrong Place: Visceral Fat and Nonalcoholic Steatohepatitis
- (2011) G. Perseghin DIABETES CARE
- Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance
- (2011) Gerhard Poelzl et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Noninvasive Tools to Assess Hepatic Fibrosis: Ready for Prime Time?
- (2011) Paul A. Schmeltzer et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Role of osteopontin in heart failure associated with aging
- (2010) Mahipal Singh et al. HEART FAILURE REVIEWS
- Effects of Hepatic Triglyceride Content on Myocardial Metabolism in Type 2 Diabetes
- (2010) Luuk J. Rijzewijk et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease
- (2010) Takhar Kasumov et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
- (2009) Carolyn S.P. Lam et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
- (2008) Janus P. Ong et al. JOURNAL OF HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More